Delta +-thalassemia in Sardinia

Area of Science:

• Molecular Biology
• Genetics
• Hematology

Background:

• Thalassemia syndromes result from reduced or absent globin chain synthesis.
• Delta-thalassemia is characterized by reduced or absent delta-globin synthesis.
• Previous delta-thalassemia types include delta 0-thalassemia with no delta-globin production.

Purpose of the Study:

• To define a novel form of delta-thalassemia.
• To characterize the molecular basis and genetic implications of this new variant.
• To differentiate it from existing delta-thalassemia classifications.

Main Methods:

• Analysis of beta-globin chain synthesis.
• Assessment of Hemoglobin A2 (HbA2) levels in affected individuals.
• Genetic analysis using polymorphic restriction endonuclease sites to identify the specific chromosome.

Main Results:

• A new delta-thalassemia type, termed delta +-thalassemia, was identified.
• This condition involves incomplete suppression of beta-globin chain synthesis.
• Homozygotes exhibit unusually low HbA2 levels, which are normalized in double heterozygotes with beta-thalassemia.

Conclusions:

• Delta +-thalassemia represents a distinct genetic variant within the thalassemia spectrum.
• The incomplete suppression of beta-globin synthesis is a key feature.
• This finding provides new insights into hemoglobinopathies and genetic interactions in thalassemia.